Häufigkeit und regionale Verteilung des Typ-2-Diabetes in Deutschland – Aktuelle Zahlen aus epidemiologischen Studien

Die Relevanz des Typ-2-Diabetes ergibt sich u. a. aus der Erkrankungshäufigkeit in der Bevölkerung. Genaue Schätzungen und langfristige Beobachtungen (Surveillance) der Erkrankungshäufigkeit sind jedoch mit methodischen Tücken behaftet. Die Zielsetzung der aktuellen Übersicht ist die Zusammenfassung aktueller epidemiologischer Daten zur Häufigkeit und regionalen Verteilung des Typ-2-Diabetes in Deutschland.

The relevance of type 2 is due, among other factors, to the incidence of the disease in the general population. More exact estimations and long-term observations (surveillance) on the frequency of the disease are, however, accompanied by methodological deficits. The objective of the present review is to survey the current epidemiological data on the incidence and regional distribution of type 2 diabetes in Germany.

Key words

type 2 diabetes - Germany - incidence - regional distribution

• Literatur

• 1 Heidemann C, Du Y, Schubert I, Rathmann W, Scheidt-Nave C. Prävalenz und zeitliche Entwicklung des bekannten Diabetes mellitus. Bundesgesundheitsblatt – Gesundheitsforschung – Gesundheitsschutz 2013; 56: 668-677
• 2 Schipf S, Werner A, Tamayo T et al. Regional differences in the prevalence of known type 2 diabetes mellitus in 45–74 years old individuals: Results from six population-based studies in Germany (DIAB-CORE Consortium). Diabet Med 2012; 29: 88-95
• 3 Robert Koch-Institut Hrsg. Daten und Fakten: Ergebnisse der Studie »Gesundheit in Deutschland aktuell 2010«. Beiträge zur Gesundheitsberichterstattung des Bundes. Berlin: RKI; 2012
• 4 Icks A, Claessen H, Strassburger K et al. Drug costs in prediabetes and undetected diabetes compared with diagnosed diabetes and normal glucose tolerance: results from the population-based KORA Survey in Germany. Diabetes Care 2013; 36: 53-54
• 5 Kitada S, Otsuka Y, Kokubu N et al. Post-load hyperglycemia as an important predictor of long-term adverse cardiac events after acute myocardial infarction: a scientific study. Cardiovasc Diabetol 2010; 9: 75-75
• 6 Kowall B, Rathmann W, Heier M et al. Categories of glucose tolerance and continuous glycemic measures and mortality. Eur J Epidemiol 2011; 26: 637-645
• 7 Bonaldi C, Vernay M, Roudier C et al. A first national prevalence estimate of diagnosed and undiagnosed diabetes in France in 18- to 74-year-old individuals: the French Nutrition and Health Survey 2006/2007. Diabet Med 2011; 28: 583-589
• 8 Rathmann W, Haastert B, Icks A et al. High prevalence of undiagnosed diabetes mellitus in Southern Germany: target populations for efficient screening. The KORA survey 2000. Diabetologia 2003; 46: 182-189
• 9 Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS. Comparison of diabetes diagnostic categories in the U.S. population according to the 1997 American Diabetes Association and 1980–1985 World Health Organization diagnostic criteria. Diabetes Care 1997; 20: 1859-1862
• 10 de Vegt F, Dekker JM, Jager A et al. Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study. JAMA 2000; 285: 2109-2113
• 11 Faerch K, Witte DR, Tabák AG et al. Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall II cohort study. Lancet Diabetes & Endocrinology (E-pub) 2013;
• 12 Wilke T, Ahrendt P, Schwartz D et al. Incidence and prevalence of type 2 diabetes mellitus in Germany: an analysis based on 5,43 Million patients. DMW 2013; 138: 69-75
• 13 Schipf S, Ittermann T, Tamayo T et al. Regional differences in the incidence of known type 2 diabetes mellitus in Germany. Posterpresentation at EASD congress 23–27.6.2013, Barcelona. Diabetologia 2013;
• 14 Wiesner G, Bittner EK. Life expectancy, potential years of life lost (PYLL), an avoidable mortality in an East/West comparison. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 47: 266-278
• 15 Meisinger C, Heier M, Völzke H et al. Regional disparities of hypertension prevalence and management within Germany. J Hypertens 2006; 24: 293-299
• 16 Stang A, Döring A, Völzke H et al. Regional differences in body fat distributions among people with comparable body mass index: a comparison across six German population-based surveys. Eur J Cardiovasc Prev Rehabil 2011; 18: 106-114
• 17 Tamayo T, Schunk M, Maier W et al. Prävalenz des unentdeckten Typ-2-Diabetes, der abnormen Nüchternglukose und der gestörten Glukosetoleranz in zwei Regionen Deutschlands. Abstract der 48. Jahrestagung der Deutschen Diabetes Gesellschaft (DDG). 8.–11.5.2013. Diabetologie und Stoffwechsel 2013; 8
• 18 Müller G, Kluttig A, Greiser KH. Regional and Neighborhood Disparities in the Odds of Type 2 Diabetes: Results From 5 Population-Based Studies in Germany (DIAB-CORE Consortium). Am J Epidemiol 2013; 178: 221-230
• 19 Maier W, Holle R, Hunger M et al. The Diabetes Collaborative Research of Epidemiologic Studies DIAB-CORE consortium. The impact of regional deprivation and individual socio-economic status on the prevalence of Type 2 diabetes in Germany. A pooled analysis of five population-based studies.